A detailed history of Sage Mountain Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sage Mountain Advisors LLC holds 5,342 shares of BMY stock, worth $303,425. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,342
Holding current value
$303,425
% of portfolio
0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$39.66 - $51.75 $211,863 - $276,448
5,342 New
5,342 $276,000
Q1 2024

Apr 23, 2024

BUY
$47.98 - $54.4 $238,652 - $270,585
4,974 New
4,974 $269,000
Q3 2023

Oct 25, 2023

SELL
$57.89 - $64.73 $40,580 - $45,375
-701 Reduced 10.62%
5,897 $342,000
Q2 2023

Jul 24, 2023

BUY
$63.71 - $70.74 $67,596 - $75,055
1,061 Added 19.16%
6,598 $421,000
Q1 2023

Apr 25, 2023

BUY
$65.71 - $74.53 $129,580 - $146,973
1,972 Added 55.32%
5,537 $383,000
Q4 2022

Feb 01, 2023

BUY
$68.48 - $81.09 $244,131 - $289,085
3,565 New
3,565 $256,000
Q2 2022

Aug 01, 2022

SELL
$72.62 - $79.98 $50,398 - $55,506
-694 Reduced 15.87%
3,678 $283,000
Q1 2022

Aug 25, 2022

SELL
$61.48 - $73.72 $51,397 - $61,629
-836 Reduced 16.05%
4,372 $319,000
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $16,292 - $19,535
-265 Reduced 4.84%
5,208 $380,000
Q4 2021

Feb 02, 2022

SELL
$53.63 - $62.52 $71,703 - $83,589
-1,337 Reduced 19.63%
5,473 $341,000
Q3 2021

Nov 01, 2021

SELL
$59.17 - $69.31 $118 - $138
-2 Reduced 0.03%
6,810 $403,000
Q2 2021

Jul 22, 2021

BUY
$61.91 - $67.42 $421,730 - $459,265
6,812 New
6,812 $455,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sage Mountain Advisors LLC Portfolio

Follow Sage Mountain Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Mountain Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Mountain Advisors LLC with notifications on news.